10-Q: Research Solutions Reports Q2 2025 Results: Platform Revenue Surges, Net Loss Widens Due to Acquisition-Related Expenses

Research Solutions, Inc. reports a 15.5% increase in total revenue for the quarter ended December 31, 2024, driven by platform growth, but net loss widens due to changes in the fair value of contingent earnout liability.

Summary

• Research Solutions, Inc. reported its financial results for the second quarter of fiscal year 2025, ended December 31, 2024.
• Total revenue increased by 15.5% to $11.91 million compared to $10.31 million in the same period last year, driven by a 47.2% increase in platform revenue.
• Platform revenue reached $4.60 million, up from $3.13 million, due to new deployments, expansion from existing customers, and the Scite acquisition.
• Transaction revenue saw a slight increase of 1.7% to $7.31 million.
• The company reported a net loss of $1.98 million, significantly higher than the $53,628 loss in the prior year, primarily due to a $2.41 million change in the fair value of contingent earnout liability related to the Scite acquisition.
• Operating expenses increased by 16.8% to $5.73 million, driven by higher sales and marketing, and technology and product development costs.
• Adjusted EBITDA increased to $962,956 from $318,469 in the prior year.
• For the six months ended December 31, 2024, total revenue increased by 17.6% to $23.96 million compared to $20.37 million in the same period last year.
• The net loss for the six months was $1.31 million, compared to a net loss of $1.04 million in the prior year.
• Cash and cash equivalents increased to $7.70 million as of December 31, 2024, from $6.10 million as of June 30, 2024.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While revenue growth is positive, the increased net loss due to acquisition-related expenses tempers the overall outlook.

Positives

• Platform revenue experienced substantial growth, increasing by 47.2% for the quarter and 56.0% for the six months ended December 31, 2024.
• Total revenue increased by 15.5% for the quarter and 17.6% for the six months ended December 31, 2024.
• Cash and cash equivalents increased to $7.70 million as of December 31, 2024, providing financial flexibility.
• Adjusted EBITDA increased to $962,956 for the three months ended December 31, 2024, indicating improved operational performance before certain non-cash and non-recurring items.

Negatives

• The company reported a significant net loss of $1.98 million for the quarter ended December 31, 2024, primarily due to a $2.41 million change in the fair value of contingent earnout liability related to the Scite acquisition.
• Transaction revenue growth was minimal, increasing by only 1.7% for the quarter and 2.6% for the six months ended December 31, 2024.
• Operating expenses increased by 16.8% for the quarter and 8.1% for the six months ended December 31, 2024, impacting overall profitability.

Risks

• The change in fair value of contingent earnout liability related to the Scite acquisition can significantly impact net income.
• Increased operating expenses may continue to pressure profitability.
• The company's future performance is subject to various risks, including those outlined in its Annual Report on Form 10-K.

Future Outlook

The company plans to release several new Platform solutions to enhance research workflows and add new solutions to support analysis functions.

Industry Context

The company operates in the vertical SaaS and AI space, providing software and related services to research-intensive organizations. The company's platforms enable life science and other research-intensive organizations to simplify their research and development activities through advanced search, access, and management tools.

Comparison to Industry Standards

• It's difficult to provide a precise comparison without knowing the specific growth rates and financial metrics of direct competitors.
• However, the 47.2% growth in platform revenue suggests a strong competitive position in the SaaS segment.
• Companies like Clarivate Analytics and RELX Group (Elsevier) are major players in the broader scientific and technical information market, but their business models and revenue streams are diverse, making direct comparisons challenging.
• The company's focus on AI-powered solutions and generative AI assistants aligns with current industry trends.

Management Changes

Stakeholder Impact

• Shareholders may be concerned about the increased net loss, but encouraged by the revenue growth and strategic acquisitions.
• Employees may benefit from the company's growth and expansion.
• Customers should see improved services and platform capabilities due to the company's investments in AI and new solutions.

Next Steps

• The company plans to release several new Platform solutions to enhance the research workflows described above and add new solutions to support the analysis functions that exist in our typical customer base.

Key Dates